Eugenosedin-A amelioration of lipopolysaccharide-induced up-regulation of p38 MAPK, inducible nitric oxide synthase and cyclooxygenase-2

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 6, 2007, Pages 879-889

  Shen, Kuo Ping ^a   Liou, Shu Fen ^b   Hsieh, Su Ling ^c   Chen, Ing Jun ^d   Wu, Bin Nan ^d,e  

^a MEIHO UNIVERSITY   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; ASCORBIC ACID; CYCLOOXYGENASE 2; EUGENOSEDIN A; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; SEROTONIN ANTAGONIST; TRAZODONE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ENDOTOXEMIA; LYMPHOCYTE; NONHUMAN; RAT; SEPTIC SHOCK;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; ASCORBIC ACID; BLOTTING, WESTERN; CYCLOOXYGENASE 2; ENDOTOXEMIA; GUANIDINES; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE TYPE II; ORGAN SPECIFICITY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PIPERAZINES; RATS; RATS, WISTAR; SEROTONIN ANTAGONISTS; TRAZODONE; UP-REGULATION; YOHIMBINE;

EID: 34447328488     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.6.0015     Document Type: Article

References (49)

1. Amin, A. R., Vyas, P., Attur, M., Leszczynska-Piziak, J., Patel, I. R., Weissmann, G., Abramson, S. B. (1995) The model of action of aspirin-like drugs: effect of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA 92: 7926-7930
2. Bharadwaj, L. A., Prasad, K. (1997) Mechanism of hydroxyl radical-induced modulation vascular tone. Free Radic. Biol. Med. 22: 381-390
3. Blackwell, T. S., Blackwell, T. R., Holden, E. P., Christman, B. W., Christman, J. W. (1996) In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation. J. Immunol. 157: 1630-1637
4. Branger, J., van den Blink, B., Weijer, S., Madwed, J., Bos, C. L., Gupta, A., Yong, C. L., Polmar, S. H., Olszyna, D. P., Hack, C. E., van Deventer, S. J., Peppelenbosch, M. P., van der Poll, T. (2002) Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. J. Immunol. 168: 4070-4077
5. Chang, S. W., Westcott, J. Y., Pickett, W. C., Murphy, R. C., Voelkel, N. F. (1989) Endotoxin-induced lung injury in rats: role of eicosanoids. J. Appl. Physiol. 66: 2407-2418
6. Cheng, Z. J., Lin, C. N., Hwang, T. L., Teng, C. M. (2001) Broussochalcone A, a potent antioxidant and effective suppressor of inducible nitric oxide synthase in lipopolysaccharide-activated macrophages. Biochem. Pharmacol. 61: 939-946
7. Chi, D. S., Qui, M., Krishnawamy, G., Li, C., Stone, W. (2003) Regulation of nitric oxide production from macrophages by lipopolysaccharide and catecholamines. Nitric Oxide 8: 127-132
8. Egger, T., Schuligoi, R., Wintersperger, A., Amann, R., Malle, E., Sattler, W. (2003) Vitamin E (α-tocopherol) attenuates cyclooxygenase 2 transcription and synthesis in immortalized murine BV-2 microglia. Biochem. J. 370: 459-467
9. 2 Adrenoceptor blockade protects rats against lipopolysaccharide. Am. J. Respir. Crit. Care Med. 154: 1689-1693
10. 2A receptors. J. Cell Physiol. 175: 341-347
11. Gupta, A., Brahmbhatt, S., Sharma, A. C. (2004) Left ventricular mitogen activated protein kinase signaling following polymicrobial sepsis during streptozotocin-induced hyperglycemia. Biochim. Biophys. Acta 1690: 42-53
12. Gutteridge, J. M. C. (1995) Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin. Chem. 41: 1819-1828
13. Hollenberg, M. D., Laniyonu, A. A., Saifeddine, M., Moore, G.. J. (1993) Role of the amino- and carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: evidence for receptor subtypes. Mol. Pharmacol. 43: 921-930
14. Hsiao, G., Teng, C. M., Sheu, J. R., Cheng, Y. W., Lam, K. K., Lee, Y. M., Wu, T. S., Yen, M. H. (2001) Cinnamophilin as a novel antiperoxidative cytoprotectant and free radical scavenger. Biochim. Biophys. Acta 1525: 77-88
15. Hsiao, G., Shen, M. Y., Chang, W. C., Cheng, Y. W., Pan, S. L., Kuo, Y. H., Chen, T. F., Sheu, J. R. (2003) A novel antioxidant, octyl caffeate, suppression of LPS/IFN-γ-induced inducible nitric oxide synthase gene expression in rat aortic smooth muscle cells. Biochem. Pharmacol. 65: 1383-1392
16. 2 production by vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 194: 420-424
17. 2-) regulatory pathways. J. Immunol. 157: 2129-2135
18. Jeon, Y. J., Kim, Y. K., Lee, M., Park, S. M., Han, S. B., Kim, H. M. (2000) Radicicol suppresses expression of inducible nitric-oxide synthase by blocking p38 kinase and nuclear factor-kappaB/Rel in lipopolysaccharide- stimulated macrophages. J. Pharmacol. Exp. Ther. 294: 548-554
19. Jones, D. S. (2002) Pharmaceutical statistics. The Pharmaceutical Press, London
20. Kazerani, H. R., Furman, B. L. (2006) Comparison of urethane/chloralose and pentobarbitone anesthesia for examining effects of bacterial lipopolysaccharide in mice. Fundam. Clin. Pharmacol. 20:379-384
21. Kristof, A. S., Marks-Konzalik, J., Moss, J. (2001) Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation. J. Biol. Chem. 276: 8445-8452
22. Kudo I, Murakami M (2005) Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. J. Biochem. Mol. Biol. 38: 633-638
23. Kuo, P. C., Abe, K., Schroeder, R. A. (2000) Superoxide enhances interleukin 1β-mediated transcription of the hepatocyte-inducible nitric oxide synthase gene. Gastroenterology 118: 608-618
24. Liu, K. L., Chen, H. W., Wang, R. Y., Lei, Y. P., Sheen, L. Y., Lii, C. K. (2006) DATS reduces LPS-induced iNOS expression, NO production, oxidative stress, and NF-κB activation in RAW 264. 7 macrophages. J. Agric. Food Chem. 54: 3472-3478
25. Matoba, T., Shimokawa, H., Nakashima, M., Hirakawa, Y., Mukai, Y., Hirano, K., Kanaide, H., Takeshita, A. (2000) Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J. Clin. Invest. 106: 1521-1530
26. Mian, K. B., Martin, W. (1995) The inhibitory effect of 3-amino-1,2,4-triazole on relaxation induced by hydroxylamine and sodium azide but not hydrogen peroxide of glyceryl trinitrate in rat aorta. Br. J. Pharmacol. 116: 3302-3308
27. Nick, J. A., Young, S. K., Brown, K. K., Avdi, N. J., Arndt, P. G., Suratt, B. T., Janes, M. S., Henson, P. M., Worthen, G. S. (2000) Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J. Immunol. 164: 2151-2159
28. 2-adrenergic receptor sensitivity. J. Pharmacol. Exp. Ther. 297: 680-687
29. Ono, K., Han, J. (2000) The p38 signal transduction pathway: activation and function. Cell. Signal. 12: 1-13
30. Posadas, I., Terencio, M. C., Guillén, I., Ferrándiz, M. L., Coloma, J., Payá, M., Alcaraz, M. J. (2000) Co-regulation between cyclooxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation. Naunyn Schmiedebergs Arch. Pharmacol. 361: 98-106
31. Ristimäki, A., Garfinkel, S., Wessendorf, J., Maciag, T., Hla, T. (1994) Induction of cyclooxygenase-2 by interleukin-1α. Evidence for post-transcriptional regulation. J. Biol. Chem. 269: 11769-11775
32. Salvemini, D., Seibert, K., Masferrer, T. P., Currie, M. G., Needleman, P. (1994) Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J. Clin. Invest. 93: 1940-1947
33. Salvemini, D., Settle, S. L., Masferrer, J. L., Seibert, K., Currie, M. G., Needleman, P. (1995) Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br. J. Pharmacol. 114: 1171-1178
34. Shen, K. P., Chiu, C. C., Chen, S. J., Chen, I. J., Wu, B. N. (2004) Hypotensive effects of eugenosedin-A with serotonin, α- and β-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats. Pharmacology 71: 91-101
35. Shen, K. P., Lo, Y. C., Yang, R. C., Liu, H. W., Chen, I. J., Wu, B. N. (2005) Antioxidant eugenosedin-A protects against lipopolysaccharide-induced hypotension, hyperglycaemia and cytokine immunoreactivity in rats and mice. J. Pharm. Pharmacol. 57: 117-125
36. Smejkal-Jagar, L., Boranic, M. (1994) Serotonin, serotonergic agents and their antagonists suppress humoral immune reaction in vitro. Res. Exp. Med. 194: 297-304
37. Spengler, R. N., Allen, R. M., Remick, D. G., Strieter, R. M., Kunkel, S. L. (1990) Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J. Immunol. 145: 1430-1434
38. Suh, S. J., Chung, T. W., Son, M. J., Kim, S. H., Moon, T. C., Son, K. H., Kim, H. P., Chang, H. W., Kim, C. H. (2006) The naturally occurring biflavonoid, ochnaflavone, inhibits LPS-induced iNOS expression, which is mediated by ERK1/2 via NF-κB regulation, in RAW264. 7 cells. Arch. Biochem. Biophys. 447: 136-146
39. 2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc. Natl. Acad. Sci. USA 91: 12168-12172
40. Tetsuka, T., Daphna-Iken, D., Miler, B. W., Guan, Z., Baier, L. D., Morrison, A. R. (1996) Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. J. Clin. Invest. 97: 2051-2056
41. Uhlig, S., Nüsing, R., Bethmann, A. V., Featherstone, R. L., Klein, T., Brasch, F., Müller, K. M., Ullrich, V., Wendel, A. (1996) Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin. Mol. Med. 2: 373-383
42. Watkins, D. N., Garlepp, M. J., Thompson, P. J. (1997) Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide. Br. J. Pharmacol. 121: 1482-1488
43. 1- adrenoceptor antagonists derived from vanillin. Biochem. Pharmacol. 48: 101-109
44. + channels opening activities in rat aortic smooth muscle. Br. J. Pharmacol. 134: 265-274
45. Wu, B. N., Chen, C. W., Liou, S. F., Yeh, J. L., Chung, H. H., Chen, I. J. (2006) Inhibition of pro-inflammatory TNF-α-induced iNOS by xanthine-based KMUP-1 and KMUP-3 in rat trachea: the involvement of soluble guanylate cyclase and protein kinase G. Mol. Pharmacol. 70: 977-985
46. Wu, F., Tyml, K., Wilson, J. X. (2002) Ascorbate inhibits iNOS expression in endotoxin and IFNγ-stimulated rat skeletal muscle endothelial cells. FEBS Lett. 520: 122-126
47. Wu, F., Wilson, J. X., Tyml, K. (2004) Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting inducible nitric oxide synthase expression. Free Radic. Biol. Med. 37: 1282-1289
48. Yang, Z. W., Zheng, T., Zhang, A., Altura, B. T., Altura, B. M. (1998) Mechanisms of hydrogen peroxide-induced contraction of rat aorta. Eur. J. Pharmacol. 344: 169-181
49. Zweier, J. L., Talukder, M. A. (2006) The role of oxidants and free radicals in reperfusion injury. Cardiovasc. Res. 70: 181-190